Aligos Therapeutics, Inc.
MODULATORS OF THR-BETA AND METHODS OF USE THEREOF

Abstract:

Disclosed herein are compounds of Formula I': ##STR00001## or a stereoisomer or a tautomer thereof, or a pharmaceutically acceptable salt thereof, pharmaceutical compositions comprising such compounds, and methods of treating disease by administering or contacting a patient with one or more of the above compounds.